keyword
https://read.qxmd.com/read/35809932/long-term-low-dose-azithromycin-for-uncontrolled-asthma-in-children
#21
EDITORIAL
Dennis Thomas, Peter G Gibson
No abstract text is available yet for this article.
July 2022: Chest
https://read.qxmd.com/read/35786264/severity-assessment-and-management-of-community-acquired-pneumonia-a-retrospective-clinical-audit
#22
JOURNAL ARTICLE
Hamza Yazji, MohammedSaeb Al-Jadba, Mohammed Sammour, Mohammed Alkhatib, Alaa-Eldeen Elmassry
BACKGROUND: Community-acquired pneumonia (CAP) is one of the most common infectious diseases and is an important cause of mortality and morbidity worldwide. Appropriate management of CAP includes accurate assessment of disease severity at the time of admission, to indicate the optimal intervention. This clinical audit aimed to evaluate the severity assessment and management of patients who presented with CAP to the emergency department at Nasser Hospital, Khan Younis, Gaza Strip, occupied Palestinian territory...
June 2022: Lancet
https://read.qxmd.com/read/35774698/azithromycin-induced-liver-injury-in-an-asthma-exacerbation-patient-with-autoimmune-features
#23
Richard Liang, Adesh Ramdass
Drug-induced liver injury (DILI) is one of the leading causes of acute liver failure in the United States. Antimicrobials are the most common class of drugs implicated in this pathology. Although azithromycin has been documented as a relatively safe drug, one of its rare and potentially fatal side effects is DILI. Diagnosing DILI is difficult because it is a diagnosis of exclusion. Autoimmune hepatitis (AIH) may present similarly to DILI, and a liver biopsy may be needed to differentiate between the two conditions...
May 2022: Curēus
https://read.qxmd.com/read/35773722/mass-drug-administration-of-antibacterials-weighing-the-evidence-regarding-benefits-and-risks
#24
REVIEW
Robert J Rolfe, Hassaan Shaikh, L Gayani Tillekeratne
BACKGROUND: Mass drug administration (MDA) is a strategy to improve health at the population level through widespread delivery of medicine in a community. We surveyed the literature to summarize the benefits and potential risks associated with MDA of antibacterials, focusing predominantly on azithromycin as it has the greatest evidence base. MAIN BODY: High-quality evidence from randomized controlled trials (RCTs) indicate that MDA-azithromycin is effective in reducing the prevalence of infection due to yaws and trachoma...
June 30, 2022: Infectious Diseases of Poverty
https://read.qxmd.com/read/35755768/analysis-of-microbiological-and-clinical-characteristics-of-bacterial-infection-in-patients-with-pulmonary-infection
#25
JOURNAL ARTICLE
Taimei Duan
OBJECTIVE: Using data investigation, the microbiology of bacterial infection in patients with pulmonary infection was discussed, and its clinical characteristics were analyzed. METHODS: The clinical data of 160 patients with pulmonary infection in our hospital from March 2019 to March 2021 were collected and analyzed. Blood samples were collected and cultured, and the pathogens were identified. The distribution, constituent ratio, and drug resistance of pathogens in elderly patients with pulmonary infection were analyzed...
2022: Computational Intelligence and Neuroscience
https://read.qxmd.com/read/35633594/characteristics-phenotypes-mechanisms-and-management-of-severe-asthma
#26
REVIEW
Kian Fan Chung, Piers Dixey, Hisham Abubakar-Waziri, Pankaj Bhavsar, Pujan H Patel, Sujuan Guo, Yang Ji
Severe asthma is "asthma which requires treatment with high dose inhaled corticosteroids (ICS) plus a second controller (and/or systemic corticosteroids) to prevent it from becoming 'uncontrolled' or which remains 'uncontrolled' despite this therapy." The state of control was defined by symptoms, exacerbations and the degree of airflow obstruction. Therefore, for the diagnosis of severe asthma, it is important to have evidence for a diagnosis of asthma with an assessment of its severity, followed by a review of comorbidities, risk factors, triggers and an assessment of whether treatment is commensurate with severity, whether the prescribed treatments have been adhered to and whether inhaled therapy has been properly administered...
May 20, 2022: Chinese Medical Journal
https://read.qxmd.com/read/35626330/neutrophils-and-asthma
#27
REVIEW
Akira Yamasaki, Ryota Okazaki, Tomoya Harada
Although eosinophilic inflammation is characteristic of asthma pathogenesis, neutrophilic inflammation is also marked, and eosinophils and neutrophils can coexist in some cases. Based on the proportion of sputum cell differentiation, asthma is classified into eosinophilic asthma, neutrophilic asthma, neutrophilic and eosinophilic asthma, and paucigranulocytic asthma. Classification by bronchoalveolar lavage is also performed. Eosinophilic asthma accounts for most severe asthma cases, but neutrophilic asthma or a mixture of the two types can also present a severe phenotype...
May 8, 2022: Diagnostics
https://read.qxmd.com/read/35558351/risk-factors-and-outcomes-associated-with-antibiotic-therapy-in-children-hospitalized-with-asthma-exacerbation
#28
JOURNAL ARTICLE
Jamie M Pinto, Sarita Wagle, Lauren J Navallo, Anna Petrova
OBJECTIVE: Despite lack of benefit, antibiotics are overused in management of asthma exacerbation in children. In this study, data from a single children's hospital were analyzed to identify factors and outcomes associated with antibiotic use in children hospitalized with asthma. METHODS: The study population was identified by using administrative data from 2012 to 2015, with subsequent verification of asthma. We analyzed factors associated with antibiotic use (demographic, seasonal, clinical) and outcome (length of stay [LOS]) with respect to: 1) disposition to pediatric floor (PF) or pediatric intensive care unit (PICU); and 2) evidence of coexisting bacterial infection and/or fever...
2022: Journal of Pediatric Pharmacology and Therapeutics: JPPT: the Official Journal of PPAG
https://read.qxmd.com/read/35490266/study-effect-of-azithromycin-and-doxycycline-in-mucus-producing-and-inflammatory-signaling-pathways-of-allergic-asthma
#29
JOURNAL ARTICLE
Zhen Wang, Lihong Xin, Wen Zhang
Asthma is a respiratory disease; involving millions of people worldwide. The main cause of asthma is allergy and immune response dysregulation. The effects of azithromycin and doxycycline as asthma-controlling drugs were evaluated in this study. Mice asthma model was produced and asthmatic mice were treated with azithromycin (75 mg/kg, orally) and doxycycline (20 mg/kg, orally). Eosinophils and neutrophils count, interleukin (IL)-4, IL-5, IL-12, IL-13, and total immunoglobulin E (IgE) levels were measured. Histological study and evaluating the genes expression of Muc5ac, Muc5b, IL-33, COX2, MYD88, and TRAF6 were performed...
April 11, 2022: Iranian Journal of Allergy, Asthma, and Immunology
https://read.qxmd.com/read/35447019/mechanism-of-action-resistance-synergism-and-clinical-implications-of-azithromycin
#30
REVIEW
Mohsen Heidary, Ahmad Ebrahimi Samangani, Abolfazl Kargari, Aliakbar Kiani Nejad, Ilya Yashmi, Moloudsadat Motahar, Elahe Taki, Saeed Khoshnood
BACKGROUND: Azithromycin (AZM), sold under the name Zithromax, is classified as a macrolide. It has many benefits due to its immunomodulatory, anti-inflammatory, and antibacterial effects. This review aims to study different clinical and biochemisterial aspects and properties of this drug which has a priority based on literature published worldwide. METHODS: Several databases including Web of Science, Google Scholar, PubMed, and Scopus were searched to obtain the relevant studies...
April 21, 2022: Journal of Clinical Laboratory Analysis
https://read.qxmd.com/read/35418427/azithromycin-and-high-dose-vitamin-d-for-treatment-and-prevention-of-asthma-like-episodes-in-hospitalised-preschool-children-study-protocol-for-a-combined-double-blind-randomised-controlled-trial
#31
JOURNAL ARTICLE
Julie Nyholm Kyvsgaard, Ulrik Ralfkiaer, Nilofar Følsgaard, Trine Mølbæk Jensen, Laura Marie Hesselberg, Ann-Marie M Schoos, Klaus Bønnelykke, Hans Bisgaard, Jakob Stokholm, Bo Chawes
INTRODUCTION: Previous randomised controlled trials (RCTs) suggest antibiotics for treating episodes of asthma-like symptoms in preschool children. Further, high-dose vitamin D supplementation has been shown to reduce the rate of asthma exacerbations among adults with asthma, while RCTs in preschool children are lacking. The aims of this combined RCT are to evaluate treatment effect of azithromycin on episode duration and the preventive effect of high-dose vitamin D supplementation on subsequent episodes of asthma-like symptoms among hospitalised preschoolers...
April 13, 2022: BMJ Open
https://read.qxmd.com/read/35361633/asthma-remission-what-is-it-and-how-can-it-be-achieved
#32
REVIEW
Dennis Thomas, Vanessa M McDonald, Ian D Pavord, Peter G Gibson
Asthma treatment goals currently focus on symptom and exacerbation control rather than remission. Remission is not identical to cure, but is a step closer. This review considers the current definitions of remission in asthma, the prevalence and predictors, the pathophysiology of remission, the possibility of achieving it using the available treatment options, and the future research directions. Asthma remission is characterised by a high level of disease control, including the absence of symptoms and exacerbations, and normalisation or optimisation of lung function with or without ongoing treatment...
November 2022: European Respiratory Journal
https://read.qxmd.com/read/35348023/azithromycin-inhibits-mucin-secretion-mucous-metaplasia-airway-inflammation-and-airways-hyperresponsiveness-in-mice-exposed-to-house-dust-mite-extract
#33
JOURNAL ARTICLE
Tracy S Mann, Alexander N Larcombe, Kimberley C W Wang, Danial Shamsuddin, Katherine R Landwehr, Peter B Noble, Peter J Henry
Excessive production, secretion, and retention of abnormal mucus is a pathological feature of many obstructive airways diseases including asthma. Azithromycin is an antibiotic that also possesses immunomodulatory and mucoregulatory activities, which may contribute to the clinical effectiveness of azithromycin in asthma. The current study investigated these nonantibiotic activities of azithromycin in mice exposed daily to intranasal house dust mite (HDM) extract for 10 days. HDM-exposed mice exhibited airways hyperresponsiveness to aerosolized methacholine, a pronounced mixed eosinophilic and neutrophilic inflammatory response, increased airway smooth muscle (ASM) thickness, and elevated levels of epithelial mucin staining...
May 1, 2022: American Journal of Physiology. Lung Cellular and Molecular Physiology
https://read.qxmd.com/read/35344453/machine-learning-model-for-classification-of-predominantly-allergic-and-non-allergic-asthma-among-preschool-children-with-asthma-hospitalization
#34
JOURNAL ARTICLE
Piyush Bhardwaj, Ashish Tyagi, Shashank Tyagi, Joana Antão, Qichen Deng
OBJECTIVE: Asthma is the most frequent chronic airway illness in preschool children and is difficult to diagnose due to the disease's heterogeneity. This study aimed to investigate different machine learning models and suggested the most effective one to classify two forms of asthma in preschool children (predominantly allergic asthma and non-allergic asthma) using a minimum number of features. METHODS: After pre-processing, 127 patients (70 with non-allergic asthma and 57 with predominantly allergic asthma) were chosen for final analysis from the Frankfurt dataset, which had asthma-related information on 205 patients...
March 2023: Journal of Asthma
https://read.qxmd.com/read/35122749/carriage-and-transmission-of-macrolide-resistance-genes-in-patients-with-chronic-respiratory-conditions-and-their-close-contacts
#35
JOURNAL ARTICLE
Yiming Wang, Steven L Taylor, Jocelyn M Choo, Lito E Papanicolas, Rebecca Keating, Kate Hindmarsh, Rachel M Thomson, Lucy Morgan, Geraint B Rogers, Lucy D Burr
BACKGROUND: Long-term macrolide therapy has been shown to provide benefit to those with a range of chronic respiratory conditions. However, there remain concerns about the impact of macrolide exposure on the carriage and abundance of antibiotic resistance genes within the oropharynx. The potential for onward transmission of resistance from macrolide recipients to their close contacts is also poorly understood. RESEARCH QUESTION: Does long-term macrolide use impact carriage of resistance within the oropharyngeal microbiota in people with chronic respiratory conditions and risk of onward transmission to their close contacts? STUDY DESIGN AND METHODS: Oropharyngeal swabs were collected from 93 individuals with chronic respiratory conditions, of whom 53 were receiving long-term macrolide therapy...
February 2, 2022: Chest
https://read.qxmd.com/read/35013387/effects-of-azithromycin-on-bronchial-remodeling-in-the-natural-model-of-severe-neutrophilic-asthma-in-horses
#36
JOURNAL ARTICLE
Sophie Mainguy-Seers, Roxane Boivin, Sheila Pourali Dogaheh, Francis Beaudry, Pierre Hélie, Alvaro G Bonilla, James G Martin, Jean-Pierre Lavoie
Steroid resistance in asthma has been associated with neutrophilic inflammation and severe manifestations of the disease. Macrolide add-on therapy can improve the quality of life and the exacerbation rate in refractory cases, possibly with greater effectiveness in neutrophilic phenotypes. The mechanisms leading to these beneficial effects are incompletely understood and whether macrolides potentiate the modulation of bronchial remodeling induced by inhaled corticosteroids (ICS) is unknown. The objective of this study was to determine if adding azithromycin to ICS leads to further improvement of lung function, airway inflammation and bronchial remodeling in severe asthma...
January 10, 2022: Scientific Reports
https://read.qxmd.com/read/34957746/-long-term-macrolide-therapy-in-asthma
#37
REVIEW
Gülden Paçacı Çetin, Bahar Arslan, İnsu Yılmaz
Macrolides are antibiotics with antiviral, anti-inflammatory and immunomodulatory effects in together with their bacteriostatic effects. In addition to its beneficial effects on chronic respiratory diseases such as COPD, cystic fibrosis, diffuse panbronchiolitis, and bronchiectasis, its effects on uncontrolled severe asthma and asthma exacerbations have been the subject of research in recent years. In randomized controlled trials, azithromycin, a macrolide, has been shown to reduce asthma exacerbations and significantly improve asthma-related quality of life in both eosinophilic and non-eosinophilic asthma phenotypes...
December 2021: Tüberküloz Ve Toraks
https://read.qxmd.com/read/34881325/benefits-and-risks-of-bronchoalveolar-lavage-in-severe-asthma-in-children
#38
JOURNAL ARTICLE
Raja Ben Tkhayat, Jessica Taytard, Harriet Corvol, Laura Berdah, Blandine Prévost, Jocelyne Just, Nadia Nathan
BACKGROUND: Although bronchoscopy can be part of the exploration of severe asthma in children, the benefit of bronchoalveolar lavage (BAL) is unknown. The present study aimed to decipher whether systematic BAL during a flexible bronchoscopy procedure could better specify the characteristics of severe asthma and improve asthma management. MATERIAL AND METHODS: The study took place in two departments of a university hospital in Paris. Children who underwent flexible bronchoscopy for the exploration of severe asthma between April 2017 and September 2019 were retrospectively included...
October 2021: ERJ Open Research
https://read.qxmd.com/read/34862766/the-efficacy-and-safety-of-azithromycin-in-treatment-for-childhood-asthma-a-systematic-review-and-meta-analysis
#39
JOURNAL ARTICLE
Xiangcheng Pan, Yan Liu, Jiefeng Luo, Siyu Li, Sha Diao, Hailong Li, Liang Huang, Zhijun Jia, Lina Chen, Guo Cheng, Hanmin Liu, Lingli Zhang
BACKGROUND: Azithromycin (AZI) is increasingly used for childhood asthma despite limited and inconsistent data. We aimed to evaluate the efficacy and safety of AZI in childhood asthma. METHODS: We searched seven databases to include randomized controlled trials (RCTs) of AZI in the treatment of childhood asthma. Four reviewers independently screened the records. Risk of Bias 2 was used to assess the quality of RCTs. Risk ratios with 95% confidence interval (CI) from dichotomous outcomes, and mean difference (MD) with 95% CI from continuous outcomes were pooled...
March 2022: Pediatric Pulmonology
https://read.qxmd.com/read/34807989/macrolides-versus-placebo-for-chronic-asthma
#40
REVIEW
Krishna Undela, Lucy Goldsmith, Kayleigh M Kew, Giovanni Ferrara
BACKGROUND: Asthma is a chronic disease in which inflammation of the airways causes symptomatic wheezing, coughing and difficult breathing. Macrolides are antibiotics with antimicrobial and anti-inflammatory activities that have been explored for the long-term control of asthma symptoms. OBJECTIVES: To assess the effects of macrolides compared with placebo for managing chronic asthma. SEARCH METHODS: We searched the Cochrane Airways Group Specialised Register up to March 2021...
November 22, 2021: Cochrane Database of Systematic Reviews
keyword
keyword
97017
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.